Stay updated on ADG126 + Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and deleted Revision: v3.4.3 in the Record History.
    Difference
    0.1%
    Check dated 2026-03-19T05:41:23.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the study record history.
    Difference
    0.1%
    Check dated 2026-03-12T02:27:50.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    The history shows a new site revision v3.4.2 added, and the government funding notice as well as the v3.4.1 revision entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-11T14:16:57.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with operating status guidance. Updated the site revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.8%
    Check dated 2026-02-04T10:25:18.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The changes are primarily UI/formatting updates: the glossary display is now shown, and color-coded highlights indicate additions (green) and deletions (red), along with updated revision labeling. These adjustments do not alter core study data, eligibility, or results on the page.
    Difference
    1%
    Check dated 2026-01-28T05:57:42.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Version v3.3.4 was released on 2026-01-07 with updates to core sections including Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Study Design, Study Description, and Study Status. The prior revision v3.3.3 dated 2025-06-04 is removed.
    Difference
    1%
    Check dated 2026-01-14T02:34:47.000Z thumbnail image

Stay in the know with updates to ADG126 + Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.